Filing Details

Accession Number:
0001566028-13-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-17 14:58:04
Reporting Period:
2013-12-13
Filing Date:
2013-12-17
Accepted Time:
2013-12-17 14:58:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1463267 M Gary April C/O Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville NY 11701
President, Hcp Division No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-13 1,875 $19.59 1,875 No 4 M Direct
Common Stock Acquisiton 2013-12-13 1,874 $22.25 3,749 No 4 M Direct
Common Stock Acquisiton 2013-12-13 3,124 $31.93 6,873 No 4 M Direct
Common Stock Disposition 2013-12-13 6,873 $43.06 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-12-13 1,875 $0.00 1,875 $19.59
Common Stock Stock Option (Right to Buy) Disposition 2013-12-13 1,874 $0.00 1,874 $22.25
Common Stock Stock Option (Right to Buy) Disposition 2013-12-13 3,124 $0.00 3,124 $31.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-11-12 2019-11-12 No 4 M Direct
1,876 2011-11-10 2020-11-10 No 4 M Direct
9,376 2013-11-08 2022-11-08 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $43.07, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
  2. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
  3. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2012 Incentive Compensation Plan, which is a Rule 16b-3 Plan.
  4. The options become exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
  5. Other than the options to acquire 1,876 and 9,376 shares reflected on this form as still held by Mr. April following the reported transactions, Mr. April is also the holder of an additional option to acquire 9,375 shares of Hi-Tech common stock (for total options to acquire 19,845 shares still held by Mr. April), which option was granted in July 2012.